Neuropathological evidence indicates decreases of cholinergic interneurons with reduced choline acetyltransferase (ChAT) activities in the striatum of patients with Alzheimer’s disease [8]. This evidence concerns the gene CHAT and early-onset autosomal dominant Alzheimer disease.